Hafnia alvei endocarditis following pyelonephritis in a permanent pacemaker carrier.
Loulergue
Pierre
P
Lortholary
Olivier
O
Mainardi
Jean-Luc
JL
Lecuit
Marc
M
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000382:microbiology; D020878:Device Removal; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology*; D004756:Enterobacteriaceae Infections / Q000175:diagnosis* / Q000188:drug therapy; D005500:Follow-Up Studies; D020611:Hafnia alvei / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D010138:Pacemaker, Artificial / Q000009:adverse effects / Q000382:microbiology*; D011704:Pyelonephritis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D012008:Recurrence; D018570:Risk Assessment; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents